Clinical Trial

Adverse Events Among Hospitalized Patients in China

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn about the incidence and characteristics of adverse events (AEs) among hospitalized patients in China and to compare 4 commonly used methods for detecting these events. The main questions it aims to answer are: How common are AEs among hospitalized patients, and what are their characteristics (types, severity, and preventability) in China? How do 4 commonly used methods, including the Harvard Medical Practice Study (HMPS), Global Trigger Tool (GTT), Patient Safety Indicators (PSIs), and incident reporting systems (IRSs), compare in detecting AEs? Researchers review randomly selected medical records from 5 hospitals in China to identify AEs, assess their type, severity, and preventability, and evaluate the performance of the 4 detection methods.
Trial Details
NCT Number NCT07705204
Lead Sponsor Peking Union Medical College Hospital
Collaborators: Beijing No.6 Hospital, Beijing Longfu Hospital, Beijing Puren Hospital, Beijing Hepingli Hospital
Conditions Adverse Event
Enrollment 2,807 participants
Start Date 2025-08-28
Primary Completion 2026-03-11 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-07-15